IC
Ikarian Capital Portfolio holdings
AUM
$302M
1-Year Est. Return
65.21%
1 Year Est. Return
+65.21%
AUM
$302M
AUM Growth
-$4.71M
(-1.5%)
Holding
160
Top Buys
| 1 | +$10.5M | |
| 2 | +$10.1M | |
| 3 | +$8.15M | |
| 4 |
Insmed
INSM
|
+$7.95M |
| 5 |
Cogent Biosciences
COGT
|
+$7.44M |
Top Sells
| 1 | +$14M | |
| 2 | +$11.7M | |
| 3 | +$10.1M | |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
+$7.86M |
| 5 |
Scholar Rock
SRRK
|
+$6.91M |
Sector Composition
| 1 | Healthcare | 99.76% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cidara Therapeutics
CDTX
$2.57B
| $22.6M | 4.35% |
464,488
+215,548
|
|
||
2
Alnylam Pharmaceuticals
ALNY
$63.1B
| $18.5M | 3.54% |
56,594
+25,000
|
|
||
|
3
Insmed
INSM
$35B
| $16.5M | 3.17% |
163,751
+78,951
|
|
||
|
VRNA
4
DELISTED
Verona Pharma
VRNA
| $13.9M | 2.67% |
146,831
+16,831
|
|
||
5
Crinetics Pharmaceuticals
CRNX
$3.91B
| $12.5M | 2.39% |
433,431
-90,000
|
|
||
6
Akero Therapeutics
AKRO
$4.32B
| $11.7M | 2.25% |
220,000
-25,000
|
|
||
7
Praxis Precision Medicines
PRAX
$4B
| $11.6M | 2.24% |
276,950
+131,448
|
|
||
8
Apogee Therapeutics
APGE
$3.73B
| $10.1M | 1.94% |
+232,047
|
|
||
9
Vaxcyte
PCVX
$5.5B
| $9.92M | 1.9% |
305,000
+105,000
|
|
||
|
ACOG
10
Alpha Cognition
ACOG
$142M
| $8.56M | 1.64% |
917,867
-50,000
|
|
||
11
Tarsus Pharmaceuticals
TARS
$3.08B
| $7.96M | 1.53% |
196,536
-288,485
|
|
||
12
Cytokinetics
CYTK
$6.99B
| $7.71M | 1.48% |
233,464
+83,482
|
|
||
13
Sarepta Therapeutics
SRPT
$2.36B
| $7.68M | 1.48% |
449,087
+280,000
|
|
||
14
TG Therapeutics
TGTX
$5.5B
| $7.56M | 1.45% |
209,938
-127
|
|
||
|
15
Cogent Biosciences
COGT
$2.29B
| $7.44M | 1.43% |
+1,035,528
|
|
||
16
Viridian Therapeutics
VRDN
$1.98B
| $6.57M | 1.26% |
469,949
-25,000
|
|
||
17
Arvinas
ARVN
$699M
| $6.26M | 1.2% |
850,000
+620,100
|
|
||
18
Forte Biosciences
FBRX
$150M
| $6.16M | 1.18% |
476,443
-132,782
|
|
||
19
Vir Biotechnology
VIR
$803M
| $5.38M | 1.03% |
1,068,062
|
|
||
20
Catalyst Pharmaceutical
CPRX
$2.52B
| $4.55M | 0.87% |
209,649
-40,000
|
|
||
21
Delcath Systems
DCTH
$419M
| $4.38M | 0.84% |
322,390
+222,025
|
|
||
22
Jazz Pharmaceuticals
JAZZ
$8.25B
| $4.24M | 0.82% |
+40,000
|
|
||
23
CG Oncology
CGON
$3.16B
| $4.03M | 0.77% |
+155,000
|
|
||
24
Neuronetics
STIM
$178M
| $3.84M | 0.74% |
1,099,700
-300
|
|
||
25
Structure Therapeutics
GPCR
$1.58B
| $3.8M | 0.73% |
183,085
-81,000
|
|